Page last updated: 2024-09-03

tyrosyl-isoleucyl-glycyl-seryl-arginine and Stomach Neoplasms

tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with Stomach Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, YS; Nishimura, S; Sowa, M; Yashiro, M1
Chung, YS; Hirakawa, K; Matsuoka, T; Nishimura, S; Saiki, I; Sawada, T; Sowa, M; Yashiro, M1

Reviews

1 review(s) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and Stomach Neoplasms

ArticleYear
[Mechanism of peritoneal metastasis and the possibility of therapeutic agents].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:10

    Topics: Animals; Antibodies; Antineoplastic Agents; Cell Adhesion; Cell Adhesion Molecules; Humans; Hyaluronan Receptors; Hyaluronic Acid; Neoplasm Metastasis; Oligopeptides; Peritoneal Neoplasms; Stomach Neoplasms; Tumor Cells, Cultured

1996

Other Studies

1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and Stomach Neoplasms

ArticleYear
Adhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer.
    Clinical & experimental metastasis, 1998, Volume: 16, Issue:4

    Topics: Adenocarcinoma, Scirrhous; Animals; Cell Adhesion; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Oligopeptides; Peptides; Peritoneal Neoplasms; Stomach Neoplasms; Tumor Cells, Cultured

1998